DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Calabresi PA, Kieseier BC, Arnold DL. , et al; ADVANCE Study Investigators.
Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Lancet Neurol 2014;
13 (07) 657-665
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.